Influenza Vaccine in HIV

PHASE3CompletedINTERVENTIONAL
Enrollment

285

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

August 31, 2009

Conditions
InfluenzaHIV
Interventions
BIOLOGICAL

Fluviral

Trial Locations (13)

T2R 0X7

Southern Alberta Clinic, Calgary

T6G 2B7

University of Alberta Hospital, Edmonton

V6Z 1Y6

BC Center for Excellence in HIV/Aids, Vancouver

V6Z 2C7

Downtown Immunodeficiency Clinic / UBC, Vancouver

B3H 1V7

QEII HSC, Victoria General Hospital Site, Halifax

L8N 4A6

McMaster University Medical Center, Hamilton

N5Y 3H6

Infectious Disease Care Program, London

K1H 8L6

The Ottawa Hospital, General Campus, Ottawa

K1N 6N5

University of Ottawa Health Services, Toronto

M2N 3M5

Sunnybrook Health Science Center, Toronto

M5G 2N2

University Health Network, Toronto

N8W 1E3

HIV Care Program - Windsor Regional Hospital, Windsor

H2X 2P4

Immunodeficiency Service, Montreal Chest Institute, Montreal

All Listed Sponsors
collaborator

Ontario HIV Treatment Network

NETWORK

collaborator

Public Health Agency of Canada (PHAC)

OTHER_GOV

collaborator

CIHR Canadian HIV Trials Network

NETWORK

lead

Ottawa Hospital Research Institute

OTHER